Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of a meal

This publication has 27 references indexed in Scilit:

• Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
  Journal of Clinical Investigation, 1978
• Measurements of somatostatin-like immunoreactivity in plasma
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1978
• Neurotensin hyperglycemia:evidence for histamine mediation and the assessment of a possible physiologic role
  Diabetes, 1978
• A RADIOIMMUNOASSAY FOR GROWTH HORMONE RELEASE‐INHIBITING HORMONE: METHOD AND QUANTITATIVE TISSUE DISTRIBUTION
  Clinical Endocrinology, 1976
• Inhibition of basal and stimulated gastric H+ and pepsin secretion in duodenal ulcer patients by metiamide, an H-2 histamine antagonist
  Digestive Diseases and Sciences, 1976
• Cimetidine Suppression of Nocturnal Gastric Secretion in Active Duodenal Ulcer
  New England Journal of Medicine, 1976
• The Value of a Histamine H₂-Receptor Antagonist in the Management of Patients with the Zollinger-Ellison Syndrome
  New England Journal of Medicine, 1976
• Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.
  British Journal of Clinical Pharmacology, 1975
• The effect of an H2-receptor antagonist on food-stimjlated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.
  Journal of Clinical Investigation, 1975
• Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man
  Digestive Diseases and Sciences, 1974